2024-09-17 | Sale | Kymera Therapeutics, Inc. KYMR | director | | $48.28 | $651,766 | -0.74% | |
2023-09-12 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $20.00 | $6,000 | -55.11% | |
2023-09-11 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $20.01 | $107,214 | -56.49% | |
2023-08-22 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $20.01 | $372,186 | -56.96% | |
2023-08-11 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $20.00 | $28,000 | -56.52% | |
2023-07-10 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $21.58 | $431,541 | -58.52% | |
2023-05-16 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $18.05 | $107,686 | -39.43% | |
2022-12-09 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $25.03 | $375,450 | -21.44% | |
2022-05-16 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $14.59 | $51,167 | +32.21% | |
2021-08-05 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $35.09 | $905,322 | -43.94% | |
2021-08-04 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $35.00 | $147,000 | -41.71% | |
2021-07-21 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $33.17 | $415,885 | -36.47% | |
2021-07-20 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $33.05 | $160,689 | -34.38% | |
2021-07-15 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $33.37 | $153,502 | -26.1% | |
2021-01-19 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $42.47 | $243,226 | -23.5% | |
2021-01-15 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $43.58 | $1.28M | -24.31% | |
2021-01-14 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $45.02 | $900,400 | -28.2% | |
2020-10-14 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $32.90 | $1.05M | -3.39% | |
2020-08-31 | Sale | Replimune Group, Inc. REPL | Chief Business Officer | | $14.03 | $140,300 | +29.85% | |